Goodrx is trading at $3.72 (+5.06%), with no clear catalyst identified for its October 26 pre-market gain. - The price is versus the $3.54 October 23 close. - No clear company-specific announcement or overnight catalyst surfaced in available news. Recent coverage points to older developments, including the September Companion Family Plan launch. - Broader market signals are mixed, and the supplied context does not establish a market-wide reason for the move; the cause remains unclear.